SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5b18'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Y_B_MK1B524_2
(PROTEIN (PROTEASE))		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.17A 1c6yB-5b18A:
17.7		 1c6yB-5b18A:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Z_B_ROCB505_1
(PROTEIN (PROTEASE))		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  30
ILE A  84
 None
 0.38A 1c6zA-5b18A:
17.9		 1c6zA-5b18A:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Z_B_ROCB505_1
(PROTEIN (PROTEASE))		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
GLY A  27
ALA A  28
GLY A  49
ILE A  84
 None
 0.81A 1c6zA-5b18A:
17.9		 1c6zA-5b18A:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Z_B_ROCB505_2
(PROTEIN (PROTEASE))		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ILE A  84
 None
 0.45A 1c6zB-5b18A:
17.9		 1c6zB-5b18A:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1C6Z_B_ROCB505_2
(PROTEIN (PROTEASE))		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.61A 1c6zB-5b18A:
17.9		 1c6zB-5b18A:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1D4Y_A_TPVA501_1
(PROTEIN (HIV-1
PROTEASE))		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 ARG A   8
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.82A 1d4yA-5b18A:
18.1		 1d4yA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FB7_A_ROCA100_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ALA A  28
ASP A  30
THR A  80
PRO A  81
ILE A  84
 None
 0.50A 1fb7A-5b18A:
18.0		 1fb7A-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FB7_A_ROCA100_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.69A 1fb7A-5b18A:
18.0		 1fb7A-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1FB7_A_ROCA100_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
ILE A  84
 None
 0.44A 1fb7A-5b18A:
18.0		 1fb7A-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSG_B_MK1B902_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.41A 1hsgB-5b18A:
18.1		 1hsgB-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_A_MK1A401_2
(HIV-II PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ALA A  28
ILE A  32
VAL A  47
PRO A  81
ILE A  84
 None
 0.76A 1hshB-5b18A:
18.2		 1hshB-5b18A:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_C_MK1C402_1
(HIV-II PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.45A 1hshC-5b18A:
17.9		 1hshC-5b18A:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_C_MK1C402_1
(HIV-II PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
ILE A  84
 None
 0.37A 1hshC-5b18A:
17.9		 1hshC-5b18A:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HSH_C_MK1C402_1
(HIV-II PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.72A 1hshC-5b18A:
17.9		 1hshC-5b18A:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  48
GLY A  49
 None
 0.85A 1hxbA-5b18A:
18.1		 1hxbA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  48
ILE A  84
 None
 0.36A 1hxbA-5b18A:
18.1		 1hxbA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.67A 1hxbA-5b18A:
18.1		 1hxbA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXB_A_ROCA100_4
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 4 GLY A  27
ASP A  29
GLY A  48
THR A  80
 None
 0.46A 1hxbB-5b18A:
18.1		 1hxbB-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXW_B_RITB301_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 GLY A  27
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.90A 1hxwA-5b18A:
18.2		 1hxwA-5b18A:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1HXW_B_RITB301_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 GLY A  27
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.58A 1hxwA-5b18A:
18.2		 1hxwA-5b18A:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1K6C_B_MK1B902_2
(POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
 None
 0.65A 1k6cB-5b18A:
18.1		 1k6cB-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1K6C_B_MK1B902_2
(POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
GLY A  49
 None
 0.88A 1k6cB-5b18A:
18.1		 1k6cB-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1MUI_B_AB1B100_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.28A 1muiA-5b18A:
17.9		 1muiA-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1MUI_B_AB1B100_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.69A 1muiA-5b18A:
17.9		 1muiA-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1MUI_B_AB1B100_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 1.09A 1muiB-5b18A:
18.0		 1muiB-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_B_RITB301_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ARG A   8
ASN A  25
GLY A  27
ALA A  28
ASP A  30
 None
 0.74A 1n49B-5b18A:
17.8		 1n49B-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_B_RITB301_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ARG A   8
ASN A  25
GLY A  27
ALA A  28
GLY A  49
 None
 0.90A 1n49B-5b18A:
17.8		 1n49B-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_B_RITB301_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ARG A   8
ASN A  25
GLY A  27
ASP A  30
ILE A  84
 None
 0.78A 1n49B-5b18A:
17.8		 1n49B-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_D_RITD401_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ARG A   8
ASN A  25
GLY A  27
ALA A  28
ASP A  30
 None
 0.74A 1n49C-5b18A:
17.6		 1n49C-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_D_RITD401_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ARG A   8
ASN A  25
GLY A  27
ALA A  28
GLY A  49
 None
 0.89A 1n49C-5b18A:
17.6		 1n49C-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1N49_D_RITD401_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ARG A   8
ASN A  25
GLY A  27
ASP A  30
ILE A  84
 None
 0.75A 1n49C-5b18A:
17.6		 1n49C-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OHR_A_1UNA201_1
(ASPARTYLPROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.80A 1ohrA-5b18A:
18.4		 1ohrA-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1OHR_A_1UNA201_1
(ASPARTYLPROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
PRO A  81
ILE A  84
 None
 0.62A 1ohrA-5b18A:
18.4		 1ohrA-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDT_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.46A 1sdtB-5b18A:
18.0		 1sdtB-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDU_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.38A 1sduB-5b18A:
18.3		 1sduB-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDU_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.74A 1sduB-5b18A:
18.3		 1sduB-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDV_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.50A 1sdvB-5b18A:
17.9		 1sdvB-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SDV_B_MK1B902_2
(PROTEASE RETROPEPSIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 1.24A 1sdvB-5b18A:
17.9		 1sdvB-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1SGU_B_MK1B2632_2
(POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
PRO A  81
 None
 0.45A 1sguB-5b18A:
18.3		 1sguB-5b18A:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T3R_A_017A1200_1
(PROTEASE RETROPEPSIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.60A 1t3rA-5b18A:
18.6		 1t3rA-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7I_A_017A200_1
(POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.61A 1t7iA-5b18A:
18.3		 1t7iA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1T7J_A_478A200_1
(POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.73A 1t7jA-5b18A:
18.3		 1t7jA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AQU_B_DR7B300_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 10 ARG A   8
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 1.10A 2aquA-5b18A:
18.1		 2aquA-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AQU_B_DR7B300_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 ARG A   8
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 1.14A 2aquB-5b18A:
18.1		 2aquB-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVO_B_MK1B902_2
(POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 1.10A 2avoB-5b18A:
18.3		 2avoB-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVS_B_MK1B902_1
(POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  30
GLY A  48
GLY A  49
ILE A  84
 None
 0.82A 2avsA-5b18A:
18.0		 2avsA-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVS_B_MK1B902_3
(POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.72A 2avsB-5b18A:
18.3		 2avsB-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVS_B_MK1B902_3
(POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ALA A  28
ASP A  29
GLY A  49
VAL A  50
ILE A  84
 None
 0.88A 2avsB-5b18A:
18.3		 2avsB-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVS_B_MK1B902_3
(POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.40A 2avsB-5b18A:
18.3		 2avsB-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_A_MK1A901_1
(POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  30
GLY A  48
ILE A  84
 None
 0.38A 2avvA-5b18A:
18.1		 2avvA-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_1
(POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  30
GLY A  48
ILE A  84
 None
 0.33A 2avvD-5b18A:
18.0		 2avvD-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_1
(POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
GLY A  48
GLY A  49
ILE A  84
 None
 0.86A 2avvD-5b18A:
18.0		 2avvD-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_3
(POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.47A 2avvE-5b18A:
18.1		 2avvE-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_3
(POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.19A 2avvE-5b18A:
18.1		 2avvE-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2AVV_E_MK1E902_3
(POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.74A 2avvE-5b18A:
18.1		 2avvE-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B60_B_RITB100_1
(GAG-POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ILE A  32
ILE A  84
 None
 0.24A 2b60A-5b18A:
18.2		 2b60A-5b18A:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B60_B_RITB100_2
(GAG-POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ARG A   8
GLY A  27
ALA A  28
ASP A  29
GLY A  49
 None
 0.73A 2b60B-5b18A:
18.2		 2b60B-5b18A:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B60_B_RITB100_2
(GAG-POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ILE A  32
ILE A  84
 None
 0.43A 2b60B-5b18A:
18.2		 2b60B-5b18A:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B7Z_B_MK1B200_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ALA A  22
 None
 1.11A 2b7zA-5b18A:
18.3		 2b7zA-5b18A:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B7Z_B_MK1B200_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.44A 2b7zB-5b18A:
18.2		 2b7zB-5b18A:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2B7Z_B_MK1B200_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.67A 2b7zB-5b18A:
18.2		 2b7zB-5b18A:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BPX_B_MK1B902_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.86A 2bpxB-5b18A:
17.7		 2bpxB-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2BPX_B_MK1B902_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.56A 2bpxB-5b18A:
17.7		 2bpxB-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F80_B_017B301_1
(POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 0.45A 2f80A-5b18A:
18.0		 2f80A-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F80_B_017B301_2
(POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.77A 2f80B-5b18A:
18.0		 2f80B-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F80_B_017B301_2
(POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 0.44A 2f80B-5b18A:
18.0		 2f80B-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_1
(POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.54A 2f81A-5b18A:
18.1		 2f81A-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_2
(POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.51A 2f81B-5b18A:
17.9		 2f81B-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F81_A_017A302_2
(POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.82A 2f81B-5b18A:
17.9		 2f81B-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F8G_B_017B401_1
(POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ALA A  28
ASP A  29
GLY A  49
VAL A  50
ILE A  84
 None
 1.03A 2f8gA-5b18A:
18.3		 2f8gA-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F8G_B_017B401_1
(POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.17A 2f8gA-5b18A:
18.3		 2f8gA-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2F8G_B_017B401_1
(POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.76A 2f8gA-5b18A:
18.3		 2f8gA-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXD_A_DR7A102_1
(POL PROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ARG A   8
ILE A  10
GLY A  27
ALA A  28
ASP A  29
GLY A  49
 None
 1.00A 2fxdA-5b18A:
17.7		 2fxdA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXD_A_DR7A102_2
(POL PROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 7 ARG A   8
ALA A  28
ASP A  29
GLY A  49
 None
 0.67A 2fxdB-5b18A:
18.0		 2fxdB-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2FXE_A_DR7A102_2
(POL PROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 ARG A   8
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 1.11A 2fxeB-5b18A:
18.4		 2fxeB-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS1_A_017A201_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
PRO A  81
ILE A  84
 None
 0.36A 2hs1A-5b18A:
16.7		 2hs1A-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS1_A_017A201_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ILE A  32
PRO A  81
ILE A  84
 None
 0.50A 2hs1B-5b18A:
17.9		 2hs1B-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS1_B_017B203_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 7 TRP A  42
PRO A  44
LYS A  55
GLY A  78
 None
 0.70A 2hs1B-5b18A:
17.9		 2hs1B-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.63A 2hs2A-5b18A:
16.6		 2hs2A-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_A_017A201_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.43A 2hs2B-5b18A:
18.1		 2hs2B-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2HS2_B_017B203_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 6 TRP A  42
PRO A  44
LYS A  55
GLY A  78
 None
 0.76A 2hs2B-5b18A:
18.1		 2hs2B-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IDW_B_017B401_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.64A 2idwB-5b18A:
18.4		 2idwB-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEN_B_017B402_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.52A 2ienB-5b18A:
18.0		 2ienB-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEN_B_017B402_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.78A 2ienB-5b18A:
18.0		 2ienB-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEO_A_017A402_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
 None
 0.64A 2ieoA-5b18A:
18.1		 2ieoA-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEO_A_017A402_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
 None
 1.24A 2ieoA-5b18A:
18.1		 2ieoA-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2IEO_A_017A402_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
 None
 0.44A 2ieoB-5b18A:
18.1		 2ieoB-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ARG A   8
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 1.30A 2nmyA-5b18A:
17.5		 2nmyA-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ARG A   8
ALA A  28
ASP A  29
ASP A  30
THR A  80
PRO A  81
ILE A  84
 None
 0.69A 2nmyA-5b18A:
17.5		 2nmyA-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.94A 2nmyA-5b18A:
17.5		 2nmyA-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
ILE A  84
 None
 0.51A 2nmyA-5b18A:
17.5		 2nmyA-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NMY_A_ROCA401_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  30
ILE A  84
 None
 0.40A 2nmyB-5b18A:
17.3		 2nmyB-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.73A 2nnkA-5b18A:
17.9		 2nnkA-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNK_A_ROCA401_3
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
GLY A  27
ASP A  29
ASP A  30
GLY A  49
 None
 0.83A 2nnkB-5b18A:
18.0		 2nnkB-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNP_A_ROCA401_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ALA A  28
ASP A  29
ASP A  30
THR A  80
PRO A  81
 None
 0.75A 2nnpA-5b18A:
17.6		 2nnpA-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNP_A_ROCA401_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.71A 2nnpA-5b18A:
17.6		 2nnpA-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2NNP_A_ROCA401_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
 None
 0.52A 2nnpA-5b18A:
17.6		 2nnpA-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
ALA A  28
ASP A  29
GLY A  48
GLY A  49
ILE A  84
 None
 1.08A 2o4kA-5b18A:
18.2		 2o4kA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4K_A_DR7A301_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
ASP A  29
GLY A  48
PRO A  81
ILE A  84
 None
 0.84A 2o4kA-5b18A:
18.2		 2o4kA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4L_A_TPVA403_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.45A 2o4lA-5b18A:
18.3		 2o4lA-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4L_A_TPVA403_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.94A 2o4lA-5b18A:
18.3		 2o4lA-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4P_A_TPVA300_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ARG A   8
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
 None
 1.24A 2o4pA-5b18A:
18.2		 2o4pA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.54A 2o4sA-5b18A:
18.3		 2o4sA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.41A 2o4sB-5b18A:
18.0		 2o4sB-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.20A 2o4sB-5b18A:
18.0		 2o4sB-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2O4S_A_AB1A400_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.73A 2o4sB-5b18A:
18.0		 2o4sB-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q5K_A_AB1A201_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
ALA A  28
ASP A  29
ASP A  30
PRO A  81
 None
 0.90A 2q5kB-5b18A:
18.0		 2q5kB-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q5K_A_AB1A201_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.58A 2q5kB-5b18A:
18.0		 2q5kB-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Q64_B_1UNB1001_1
(PROTEASE RETROPEPSIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.67A 2q64A-5b18A:
18.1		 2q64A-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_1
(PROTEASE RETROPEPSIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.56A 2qhcA-5b18A:
18.0		 2qhcA-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_1
(PROTEASE RETROPEPSIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ARG A   8
ALA A  28
ASP A  29
ASP A  30
PRO A  81
 None
 0.79A 2qhcA-5b18A:
18.0		 2qhcA-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_2
(PROTEASE RETROPEPSIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.33A 2qhcB-5b18A:
18.0		 2qhcB-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2QHC_B_AB1B9001_2
(PROTEASE RETROPEPSIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.60A 2qhcB-5b18A:
18.0		 2qhcB-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_B_MK1B902_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
PRO A  81
 None
 0.78A 2r5pB-5b18A:
18.5		 2r5pB-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_B_MK1B902_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.48A 2r5pB-5b18A:
18.5		 2r5pB-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_B_MK1B902_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 1.23A 2r5pB-5b18A:
18.5		 2r5pB-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_D_MK1D902_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
PRO A  81
 None
 0.78A 2r5pD-5b18A:
18.5		 2r5pD-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_D_MK1D902_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.48A 2r5pD-5b18A:
18.5		 2r5pD-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5P_D_MK1D902_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 1.22A 2r5pD-5b18A:
18.5		 2r5pD-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_B_1UNB900_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.84A 2r5qB-5b18A:
18.2		 2r5qB-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_B_1UNB900_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.64A 2r5qB-5b18A:
18.2		 2r5qB-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_D_1UND900_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.84A 2r5qD-5b18A:
18.2		 2r5qD-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2R5Q_D_1UND900_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.64A 2r5qD-5b18A:
18.2		 2r5qD-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKF_A_AB1A501_1
(PROTEASE RETROPEPSIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
PRO A  81
ILE A  84
 None
 0.49A 2rkfA-5b18A:
17.9		 2rkfA-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKF_A_AB1A501_1
(PROTEASE RETROPEPSIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.69A 2rkfA-5b18A:
17.9		 2rkfA-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKG_B_AB1B501_2
(PROTEASE RETROPEPSIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ASP A  29
ASP A  30
ILE A  32
PRO A  81
ILE A  84
 None
 0.54A 2rkgB-5b18A:
17.9		 2rkgB-5b18A:
74.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKG_B_AB1B501_2
(PROTEASE RETROPEPSIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
ILE A  84
 None
 0.21A 2rkgB-5b18A:
17.9		 2rkgB-5b18A:
74.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2RKG_B_AB1B501_2
(PROTEASE RETROPEPSIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.73A 2rkgB-5b18A:
17.9		 2rkgB-5b18A:
74.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Z54_A_AB1A200_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.13A 2z54A-5b18A:
18.0		 2z54A-5b18A:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Z54_A_AB1A200_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.63A 2z54A-5b18A:
18.0		 2z54A-5b18A:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Z54_A_AB1A200_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
 None
 0.81A 2z54B-5b18A:
18.0		 2z54B-5b18A:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2Z54_A_AB1A200_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 1.06A 2z54B-5b18A:
18.0		 2z54B-5b18A:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.58A 3cywA-5b18A:
18.0		 3cywA-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.85A 3cywA-5b18A:
18.0		 3cywA-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 0.49A 3cywA-5b18A:
18.0		 3cywA-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYW_A_017A201_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.39A 3cywB-5b18A:
18.0		 3cywB-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYX_A_ROCA201_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.72A 3cyxA-5b18A:
18.2		 3cyxA-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYX_A_ROCA201_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.39A 3cyxA-5b18A:
18.2		 3cyxA-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYX_A_ROCA201_3
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
ASP A  30
GLY A  48
PRO A  81
ILE A  84
 None
 0.72A 3cyxB-5b18A:
18.2		 3cyxB-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYX_A_ROCA201_3
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  30
GLY A  48
ILE A  84
 None
 0.55A 3cyxB-5b18A:
18.2		 3cyxB-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3CYX_A_ROCA201_3
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
GLY A  48
GLY A  49
ILE A  84
 None
 0.98A 3cyxB-5b18A:
18.2		 3cyxB-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1X_A_ROCA201_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ASP A  29
ASP A  30
THR A  80
PRO A  81
ILE A  84
 None
 0.82A 3d1xA-5b18A:
18.0		 3d1xA-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1X_A_ROCA201_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.87A 3d1xA-5b18A:
18.0		 3d1xA-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1X_A_ROCA201_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
ILE A  84
 None
 0.57A 3d1xA-5b18A:
18.0		 3d1xA-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1X_A_ROCA201_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.49A 3d1xB-5b18A:
18.0		 3d1xB-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1X_A_ROCA201_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  30
ILE A  84
 None
 0.38A 3d1xB-5b18A:
18.0		 3d1xB-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1X_A_ROCA201_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
GLY A  27
ALA A  28
GLY A  49
ILE A  84
 None
 0.87A 3d1xB-5b18A:
18.0		 3d1xB-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Y_A_ROCA201_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ALA A  28
ASP A  29
ASP A  30
THR A  80
PRO A  81
ILE A  84
 None
 0.66A 3d1yA-5b18A:
18.1		 3d1yA-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Y_A_ROCA201_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ALA A  28
ASP A  29
GLY A  48
THR A  80
PRO A  81
ILE A  84
 None
 1.42A 3d1yA-5b18A:
18.1		 3d1yA-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Y_A_ROCA201_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.84A 3d1yA-5b18A:
18.1		 3d1yA-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Y_A_ROCA201_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
ILE A  84
 None
 0.46A 3d1yA-5b18A:
18.1		 3d1yA-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.47A 3d1zB-5b18A:
18.1		 3d1zB-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D1Z_B_017B201_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.75A 3d1zB-5b18A:
18.1		 3d1zB-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D20_A_017A201_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.53A 3d20A-5b18A:
18.2		 3d20A-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D20_A_017A201_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.42A 3d20B-5b18A:
18.2		 3d20B-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3D20_A_017A201_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 0.97A 3d20B-5b18A:
18.2		 3d20B-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ARG A   8
ALA A  28
ASP A  30
ILE A  32
PRO A  81
ILE A  84
 None
 0.72A 3ebzA-5b18A:
17.9		 3ebzA-5b18A:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
 None
 0.48A 3ebzB-5b18A:
18.5		 3ebzB-5b18A:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EBZ_B_017B201_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 GLY A  27
ALA A  28
ASP A  29
ASP A  30
VAL A  47
GLY A  49
 None
 0.86A 3ebzB-5b18A:
18.5		 3ebzB-5b18A:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKQ_A_ROCA100_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 1.27A 3ekqA-5b18A:
18.0		 3ekqA-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKQ_A_ROCA100_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.78A 3ekqA-5b18A:
18.0		 3ekqA-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_B_017B200_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.82A 3ektA-5b18A:
18.5		 3ektA-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_D_017D200_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.46A 3ektC-5b18A:
18.3		 3ektC-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_D_017D200_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 1.05A 3ektC-5b18A:
18.3		 3ektC-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_D_017D200_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.46A 3ektD-5b18A:
18.3		 3ektD-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKT_D_017D200_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.78A 3ektD-5b18A:
18.3		 3ektD-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKV_A_478A200_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.81A 3ekvA-5b18A:
18.2		 3ekvA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKW_B_DR7B100_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 ARG A   8
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 1.20A 3ekwA-5b18A:
18.2		 3ekwA-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKW_B_DR7B100_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.89A 3ekwB-5b18A:
18.1		 3ekwB-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKW_B_DR7B100_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 0.53A 3ekwB-5b18A:
18.1		 3ekwB-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ALA A  28
ASP A  30
THR A  80
PRO A  81
ILE A  84
 None
 0.69A 3ekxA-5b18A:
17.7		 3ekxA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.83A 3ekxA-5b18A:
17.7		 3ekxA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKX_B_1UNB201_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
ILE A  84
 None
 0.52A 3ekxA-5b18A:
17.7		 3ekxA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EKY_A_DR7A100_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 10 ARG A   8
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 1.17A 3ekyA-5b18A:
18.1		 3ekyA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL0_A_1UNA201_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 8 ASP A  29
ASP A  30
THR A  80
PRO A  81
ILE A  84
 None
 0.59A 3el0A-5b18A:
17.9		 3el0A-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL0_A_1UNA201_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 8 GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
ILE A  84
 None
 0.41A 3el0A-5b18A:
17.9		 3el0A-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL1_A_DR7A100_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ARG A   8
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.85A 3el1A-5b18A:
17.9		 3el1A-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL4_A_ROCA100_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ALA A  28
ASP A  29
ASP A  30
THR A  80
PRO A  81
 None
 0.74A 3el4A-5b18A:
17.7		 3el4A-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL4_A_ROCA100_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.69A 3el4A-5b18A:
17.7		 3el4A-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL4_A_ROCA100_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
 None
 0.52A 3el4A-5b18A:
17.7		 3el4A-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL5_B_1UNB201_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
 None
 1.12A 3el5B-5b18A:
17.6		 3el5B-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL5_B_1UNB201_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
PRO A  81
 None
 0.68A 3el5B-5b18A:
17.6		 3el5B-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL9_A_DR7A100_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 8 ARG A   8
ALA A  28
ASP A  29
GLY A  49
 None
 0.78A 3el9A-5b18A:
17.6		 3el9A-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EL9_A_DR7A100_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 ARG A   8
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
 None
 1.10A 3el9B-5b18A:
18.3		 3el9B-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM3_B_478B200_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
 0.91A 3em3A-5b18A:
18.3		 3em3A-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_A_DR7A100_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 ARG A   8
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 1.28A 3em4A-5b18A:
17.8		 3em4A-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_A_DR7A100_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ARG A   8
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.71A 3em4B-5b18A:
18.0		 3em4B-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_A_DR7A100_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ARG A   8
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 0.56A 3em4B-5b18A:
18.0		 3em4B-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_V_DR7V100_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 ARG A   8
GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 1.10A 3em4U-5b18A:
18.2		 3em4U-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3EM4_V_DR7V100_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 ARG A   8
ASP A  29
GLY A  48
GLY A  49
PRO A  81
ILE A  84
 None
 1.20A 3em4V-5b18A:
18.3		 3em4V-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_1
(GAG-POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.49A 3jvyA-5b18A:
18.0		 3jvyA-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_1
(GAG-POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 0.49A 3jvyA-5b18A:
18.0		 3jvyA-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_2
(GAG-POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.66A 3jvyB-5b18A:
18.1		 3jvyB-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3JVY_B_017B401_2
(GAG-POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.71A 3jvyB-5b18A:
18.1		 3jvyB-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
 0.78A 3k4vC-5b18A:
18.1		 3k4vC-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 4 GLY A  27
ASP A  29
GLY A  48
THR A  80
 None
 0.54A 3k4vC-5b18A:
18.1		 3k4vC-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3K4V_D_ROCD201_3
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.75A 3k4vD-5b18A:
17.9		 3k4vD-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZS_A_017A200_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.40A 3lzsA-5b18A:
17.7		 3lzsA-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZS_A_017A200_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.73A 3lzsA-5b18A:
17.7		 3lzsA-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZS_A_017A200_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.49A 3lzsB-5b18A:
17.6		 3lzsB-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZS_A_017A200_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 1.10A 3lzsB-5b18A:
17.6		 3lzsB-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZU_A_017A200_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.43A 3lzuA-5b18A:
17.6		 3lzuA-5b18A:
71.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3LZU_A_017A200_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 1.08A 3lzuA-5b18A:
17.6		 3lzuA-5b18A:
71.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3MWS_B_017B201_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.53A 3mwsA-5b18A:
19.0		 3mwsA-5b18A:
64.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3N3I_A_ROCA201_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.61A 3n3iA-5b18A:
12.6		 3n3iA-5b18A:
37.44
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
 0.84A 3ndtC-5b18A:
18.1		 3ndtC-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDT_D_ROCD100_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.77A 3ndtD-5b18A:
17.9		 3ndtD-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.70A 3nduA-5b18A:
17.9		 3nduA-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_A_ROCA101_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.76A 3nduB-5b18A:
17.9		 3nduB-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_D_ROCD100_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
GLY A  27
ASP A  30
GLY A  49
ILE A  84
 None
 0.86A 3nduC-5b18A:
18.1		 3nduC-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDU_D_ROCD100_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.75A 3nduD-5b18A:
17.5		 3nduD-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDW_A_RITA100_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.30A 3ndwA-5b18A:
17.9		 3ndwA-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDW_A_RITA100_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.81A 3ndwA-5b18A:
17.9		 3ndwA-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDW_A_RITA100_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ARG A   8
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.71A 3ndwB-5b18A:
18.1		 3ndwB-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDX_A_RITA100_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.38A 3ndxA-5b18A:
17.8		 3ndxA-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDX_A_RITA100_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.83A 3ndxA-5b18A:
17.8		 3ndxA-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NDX_A_RITA100_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.80A 3ndxB-5b18A:
18.2		 3ndxB-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU3_B_478B401_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 GLY A  27
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 1.01A 3nu3B-5b18A:
18.1		 3nu3B-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU4_B_478B401_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ALA A  28
ASP A  30
ILE A  32
PRO A  81
ILE A  84
 None
 0.68A 3nu4A-5b18A:
17.9		 3nu4A-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU4_B_478B401_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
 0.90A 3nu4B-5b18A:
18.0		 3nu4B-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU4_B_478B401_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 GLY A  27
ALA A  28
ASP A  30
ILE A  32
ILE A  84
 None
 0.18A 3nu4B-5b18A:
18.0		 3nu4B-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU5_B_478B401_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.90A 3nu5B-5b18A:
18.1		 3nu5B-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU5_B_478B401_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ALA A  28
GLY A  49
VAL A  50
PRO A  81
ILE A  84
 None
 1.02A 3nu5B-5b18A:
18.1		 3nu5B-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NU5_B_478B401_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.26A 3nu5B-5b18A:
18.1		 3nu5B-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUJ_B_478B401_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
 0.86A 3nujB-5b18A:
18.1		 3nujB-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3NUO_B_478B478_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
 0.89A 3nuoB-5b18A:
18.0		 3nuoB-5b18A:
74.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OGQ_A_AB1A200_2
(FIV PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
GLY A  49
 None
 0.83A 3ogqB-5b18A:
15.0		 3ogqB-5b18A:
26.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.27A 3oxcA-5b18A:
17.3		 3oxcA-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXC_A_ROCA401_3
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
 0.89A 3oxcB-5b18A:
18.0		 3oxcB-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_B_478B200_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 GLY A  27
ALA A  28
ASP A  30
GLY A  49
VAL A  50
ILE A  84
 None
 1.26A 3oxvA-5b18A:
18.4		 3oxvA-5b18A:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXV_C_478C200_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
 0.78A 3oxvC-5b18A:
18.6		 3oxvC-5b18A:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_B_017B200_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.81A 3oxwA-5b18A:
18.5		 3oxwA-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXW_D_017D200_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.80A 3oxwC-5b18A:
18.4		 3oxwC-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_A_DR7A100_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ALA A  28
ASP A  29
GLY A  49
VAL A  50
ILE A  84
 None
 0.91A 3oxxA-5b18A:
18.0		 3oxxA-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_A_DR7A100_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.84A 3oxxA-5b18A:
18.0		 3oxxA-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_A_DR7A100_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 0.44A 3oxxA-5b18A:
18.0		 3oxxA-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_A_DR7A100_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ALA A  28
ASP A  29
GLY A  49
VAL A  50
ILE A  84
 None
 0.84A 3oxxB-5b18A:
18.3		 3oxxB-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_A_DR7A100_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ALA A  28
ASP A  29
VAL A  50
PRO A  81
ILE A  84
 None
 1.29A 3oxxB-5b18A:
18.3		 3oxxB-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_A_DR7A100_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ARG A   8
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.81A 3oxxB-5b18A:
18.3		 3oxxB-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_A_DR7A100_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ARG A   8
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 0.52A 3oxxB-5b18A:
18.3		 3oxxB-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_C_DR7C100_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
ALA A  28
ASP A  29
PRO A  81
ILE A  84
 None
 0.63A 3oxxC-5b18A:
18.0		 3oxxC-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_C_DR7C100_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
GLY A  49
 None
 0.80A 3oxxC-5b18A:
18.0		 3oxxC-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_C_DR7C100_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ILE A  84
 None
 0.41A 3oxxC-5b18A:
18.0		 3oxxC-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_C_DR7C100_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ALA A  28
ASP A  29
GLY A  49
VAL A  50
PRO A  81
ILE A  84
 None
 1.28A 3oxxD-5b18A:
18.3		 3oxxD-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OXX_C_DR7C100_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ARG A   8
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 1.11A 3oxxD-5b18A:
18.3		 3oxxD-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3OY4_B_017B200_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.57A 3oy4B-5b18A:
18.1		 3oy4B-5b18A:
74.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWM_B_017B402_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.46A 3pwmA-5b18A:
18.0		 3pwmA-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWM_B_017B402_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.76A 3pwmB-5b18A:
18.0		 3pwmB-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWM_B_017B402_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.36A 3pwmB-5b18A:
18.0		 3pwmB-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.67A 3pwrA-5b18A:
17.9		 3pwrA-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.28A 3pwrA-5b18A:
17.9		 3pwrA-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3PWR_A_ROCA401_3
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
 0.86A 3pwrB-5b18A:
17.9		 3pwrB-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S43_A_478A401_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
 0.85A 3s43B-5b18A:
18.0		 3s43B-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S43_A_478A401_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 GLY A  27
ALA A  28
ASP A  30
ILE A  32
ILE A  84
 None
 0.18A 3s43B-5b18A:
18.0		 3s43B-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ALA A  28
ASP A  30
ILE A  32
PRO A  81
ILE A  84
 None
 0.60A 3s45A-5b18A:
17.9		 3s45A-5b18A:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.68A 3s45B-5b18A:
18.5		 3s45B-5b18A:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S45_B_478B201_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
ILE A  84
 None
 0.55A 3s45B-5b18A:
18.5		 3s45B-5b18A:
47.47
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.61A 3s53A-5b18A:
16.9		 3s53A-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_A_017A201_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
 None
 0.33A 3s53A-5b18A:
16.9		 3s53A-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_B_017B203_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 5 TRP A  42
PRO A  44
LYS A  55
ARG A  57
 None
 1.12A 3s53B-5b18A:
18.0		 3s53B-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S53_B_017B203_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 5 TRP A  42
PRO A  44
LYS A  55
GLY A  78
 None
 0.66A 3s53B-5b18A:
18.0		 3s53B-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ASP A  29
ASP A  30
ILE A  32
VAL A  47
THR A  80
PRO A  81
 None
 0.75A 3s56A-5b18A:
17.0		 3s56A-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.67A 3s56A-5b18A:
17.0		 3s56A-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3S56_A_ROCA201_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
VAL A  47
THR A  80
 None
 0.53A 3s56A-5b18A:
17.0		 3s56A-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SO9_A_017A100_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ASN A  25
ALA A  28
ASP A  29
ASP A  30
PRO A  81
 None
 0.97A 3so9B-5b18A:
17.4		 3so9B-5b18A:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_A_TPVA100_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ARG A   8
ASN A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.81A 3spkA-5b18A:
18.0		 3spkA-5b18A:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_A_TPVA100_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 ASN A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
 None
 0.77A 3spkA-5b18A:
18.0		 3spkA-5b18A:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3SPK_B_TPVB100_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 ARG A   8
ASN A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
 None
 1.05A 3spkB-5b18A:
18.0		 3spkB-5b18A:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3T3C_A_017A201_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 7 GLY A  27
ALA A  28
ASP A  29
ASP A  30
 None
 0.24A 3t3cA-5b18A:
18.6		 3t3cA-5b18A:
64.65
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.73A 3tkgA-5b18A:
17.7		 3tkgA-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_B_ROCB801_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
 0.91A 3tkgB-5b18A:
18.2		 3tkgB-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.72A 3tkgC-5b18A:
17.6		 3tkgC-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
ILE A  84
 None
 0.46A 3tkgC-5b18A:
17.6		 3tkgC-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKG_C_ROCC901_3
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		3 / 3 ASP A  29
THR A  80
PRO A  81
 None
 0.65A 3tkgD-5b18A:
17.9		 3tkgD-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKW_B_017B401_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.31A 3tkwA-5b18A:
18.2		 3tkwA-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TKW_B_017B401_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.75A 3tkwA-5b18A:
18.2		 3tkwA-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TL9_A_ROCA401_4
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 4 ASP A  29
ASP A  30
GLY A  48
THR A  80
 None
 0.42A 3tl9B-5b18A:
17.0		 3tl9B-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.53A 3ttpA-5b18A:
18.5		 3ttpA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 1.13A 3ttpA-5b18A:
18.5		 3ttpA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.51A 3ttpB-5b18A:
18.4		 3ttpB-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3TTP_A_017A201_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 1.11A 3ttpB-5b18A:
18.4		 3ttpB-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3U7S_A_017A201_1
(POL POLYPROTEIN)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.71A 3u7sA-5b18A:
18.9		 3u7sA-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_A_017A201_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ILE A  32
PRO A  81
 None
 0.38A 3ucbA-5b18A:
18.3		 3ucbA-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_A_017A201_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ILE A  32
PRO A  81
 None
 0.41A 3ucbB-5b18A:
18.0		 3ucbB-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UCB_B_017B202_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 7 TRP A  42
PRO A  44
LYS A  55
GLY A  78
PRO A  79
 None
 0.73A 3ucbB-5b18A:
18.0		 3ucbB-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UFN_A_ROCA401_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 GLY A  27
ALA A  28
ASP A  29
VAL A  47
GLY A  48
GLY A  49
PRO A  81
 None
 1.35A 3ufnA-5b18A:
18.1		 3ufnA-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UFN_A_ROCA401_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 11 GLY A  27
ALA A  28
ASP A  29
VAL A  47
GLY A  48
THR A  80
PRO A  81
 None
 0.82A 3ufnA-5b18A:
18.1		 3ufnA-5b18A:
73.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4A97_A_ZPCA1318_2
(CYS-LOOP
LIGAND-GATED ION
CHANNEL)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 7 TYR A  59
VAL A  75
ILE A  64
GLU A  35
 None
 1.13A 4a97E-5b18A:
undetectable		 4a97E-5b18A:
14.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQB_B_017B101_2
(ASPARTYL PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.62A 4dqbB-5b18A:
18.4		 4dqbB-5b18A:
72.73
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQC_A_017A101_2
(ASPARTYL PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.71A 4dqcB-5b18A:
18.3		 4dqcB-5b18A:
70.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQE_B_017B101_2
(ASPARTYL PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.62A 4dqeB-5b18A:
18.4		 4dqeB-5b18A:
70.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQF_B_017B101_2
(ASPARTYL PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.61A 4dqfB-5b18A:
18.0		 4dqfB-5b18A:
70.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4DQH_B_017B101_2
(WILD-TYPE HIV-1
PROTEASE DIMER)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.62A 4dqhB-5b18A:
18.5		 4dqhB-5b18A:
71.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FQS_A_LYAA302_1
(THYMIDYLATE SYNTHASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ILE A  84
LEU A  76
GLY A  78
TYR A  59
VAL A  75
 None
 1.22A 4fqsA-5b18A:
undetectable		 4fqsA-5b18A:
16.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4FQS_B_LYAB302_1
(THYMIDYLATE SYNTHASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ILE A  84
LEU A  76
GLY A  78
TYR A  59
VAL A  75
 None
 1.23A 4fqsB-5b18A:
undetectable		 4fqsB-5b18A:
16.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.31A 4hlaA-5b18A:
18.2		 4hlaA-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.71A 4hlaA-5b18A:
18.2		 4hlaA-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 11 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.38A 4hlaB-5b18A:
18.2		 4hlaB-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4HLA_A_017A200_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.70A 4hlaB-5b18A:
18.2		 4hlaB-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4L1A_A_AB1A101_1
(MDR769 HIV-1
PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		8 / 11 ARG A   8
ASN A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
PRO A  81
 None
 0.49A 4l1aA-5b18A:
16.9		 4l1aA-5b18A:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4L1A_A_AB1A101_2
(MDR769 HIV-1
PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 6 ARG A   8
ASN A  25
ASP A  29
GLY A  48
 None
 0.57A 4l1aB-5b18A:
16.8		 4l1aB-5b18A:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4L1A_A_AB1A101_2
(MDR769 HIV-1
PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 6 ARG A   8
ASN A  25
ASP A  29
PRO A  81
 None
 0.58A 4l1aB-5b18A:
16.8		 4l1aB-5b18A:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A201_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 10 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.85A 4ll3B-5b18A:
18.2		 4ll3B-5b18A:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A202_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.37A 4ll3A-5b18A:
18.1		 4ll3A-5b18A:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A202_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.79A 4ll3A-5b18A:
18.1		 4ll3A-5b18A:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4LL3_A_017A202_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 9 ARG A   8
ALA A  28
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 1.19A 4ll3B-5b18A:
18.2		 4ll3B-5b18A:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJT_B_017B101_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.68A 4njtB-5b18A:
18.8		 4njtB-5b18A:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_A_TPVA500_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
ALA A  28
ASP A  29
ASP A  30
PRO A  81
 None
 0.51A 4njuA-5b18A:
18.3		 4njuA-5b18A:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJU_C_TPVC500_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
ALA A  28
ASP A  29
ASP A  30
PRO A  81
 None
 0.52A 4njuC-5b18A:
18.2		 4njuC-5b18A:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_A_RITA500_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.50A 4njvA-5b18A:
18.2		 4njvA-5b18A:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_A_RITA500_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.88A 4njvA-5b18A:
18.2		 4njvA-5b18A:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_A_RITA500_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ARG A   8
GLY A  27
ASP A  29
ASP A  30
ILE A  84
 None
 0.36A 4njvB-5b18A:
18.3		 4njvB-5b18A:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_A_RITA500_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ARG A   8
GLY A  27
ASP A  29
GLY A  49
ILE A  84
 None
 0.89A 4njvB-5b18A:
18.3		 4njvB-5b18A:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_D_RITD500_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 ARG A   8
GLY A  27
ASP A  29
GLY A  49
ILE A  84
 None
 0.92A 4njvC-5b18A:
18.2		 4njvC-5b18A:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_D_RITD500_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  30
ILE A  84
 None
 0.51A 4njvD-5b18A:
18.4		 4njvD-5b18A:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4NJV_D_RITD500_2
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ARG A   8
GLY A  27
ALA A  28
GLY A  49
ILE A  84
 None
 0.79A 4njvD-5b18A:
18.4		 4njvD-5b18A:
78.79
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1W_A_017A104_1
(ASPARTYL PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.63A 4q1wA-5b18A:
18.4		 4q1wA-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_1
(ASPARTYL PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.58A 4q1yA-5b18A:
18.7		 4q1yA-5b18A:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4Q1Y_A_017A106_1
(ASPARTYL PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 10 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
 None
 0.30A 4q1yA-5b18A:
18.7		 4q1yA-5b18A:
77.78
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QGI_A_ROCA101_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.70A 4qgiA-5b18A:
17.9		 4qgiA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4QGI_A_ROCA101_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 11 GLY A  27
ALA A  28
ASP A  29
ASP A  30
THR A  80
 None
 0.43A 4qgiA-5b18A:
17.9		 4qgiA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_B_478B101_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
 0.86A 4rvjB-5b18A:
18.4		 4rvjB-5b18A:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4RVJ_D_478D101_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 GLY A  27
ALA A  28
ASP A  30
GLY A  49
ILE A  84
 None
 0.86A 4rvjD-5b18A:
18.4		 4rvjD-5b18A:
79.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4YOA_A_017A100_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		4 / 6 ASN A  25
ASP A  29
THR A  80
PRO A  81
 None
 0.74A 4yoaA-5b18A:
17.6		 4yoaA-5b18A:
80.81
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5J_A_017A201_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ALA A  28
ASP A  29
ASP A  30
VAL A  47
ILE A  84
 None
 0.58A 5e5jA-5b18A:
18.1		 5e5jA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5J_A_017A201_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
ILE A  84
 None
 0.26A 5e5jA-5b18A:
18.1		 5e5jA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5J_A_017A201_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.70A 5e5jA-5b18A:
18.1		 5e5jA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5E5K_B_017B201_2
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ILE A  32
PRO A  81
ILE A  84
 None
 0.52A 5e5kB-5b18A:
18.0		 5e5kB-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KQY_B_017B101_2
(PROTEASE E35D-DRV)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 7 ASN A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.68A 5kqyB-5b18A:
18.2		 5kqyB-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR0_A_478A101_1
(PROTEASE E35D-APV)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ASN A  25
ALA A  28
ASP A  30
PRO A  81
ILE A  84
 None
 0.67A 5kr0A-5b18A:
17.8		 5kr0A-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR0_A_478A101_2
(PROTEASE E35D-APV)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ASN A  25
GLY A  27
ALA A  28
ASP A  30
GLY A  49
 None
 0.81A 5kr0B-5b18A:
18.1		 5kr0B-5b18A:
73.74
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR1_B_017B101_2
(PROTEASE PR5-DRV)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 8 ASN A  25
GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.56A 5kr1B-5b18A:
18.5		 5kr1B-5b18A:
71.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_A_ROCA101_1
(PROTEASE PR5-SQV)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ASN A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.94A 5kr2A-5b18A:
17.9		 5kr2A-5b18A:
71.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_A_ROCA101_1
(PROTEASE PR5-SQV)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ASN A  25
ALA A  28
ASP A  29
ASP A  30
THR A  80
 None
 0.71A 5kr2A-5b18A:
17.9		 5kr2A-5b18A:
71.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_A_ROCA101_1
(PROTEASE PR5-SQV)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ASN A  25
ASP A  29
ASP A  30
THR A  80
PRO A  81
 None
 0.87A 5kr2A-5b18A:
17.9		 5kr2A-5b18A:
71.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_C_ROCC101_1
(PROTEASE PR5-SQV)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ASN A  25
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.57A 5kr2C-5b18A:
17.7		 5kr2C-5b18A:
71.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_C_ROCC101_1
(PROTEASE PR5-SQV)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ASN A  25
ALA A  28
ASP A  29
ASP A  30
THR A  80
 None
 0.64A 5kr2C-5b18A:
17.7		 5kr2C-5b18A:
71.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5KR2_C_ROCC101_2
(PROTEASE PR5-SQV)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 9 ARG A   8
ASN A  25
GLY A  49
PRO A  81
ILE A  84
 None
 1.10A 5kr2D-5b18A:
17.9		 5kr2D-5b18A:
71.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T2Z_B_017B201_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  84
 None
 0.40A 5t2zA-5b18A:
17.9		 5t2zA-5b18A:
76.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T8H_B_478B401_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ASP A  29
ASP A  30
VAL A  47
PRO A  81
ILE A  84
 None
 0.67A 5t8hA-5b18A:
18.1		 5t8hA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T8H_B_478B401_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
ILE A  32
PRO A  81
ILE A  84
 None
 0.29A 5t8hA-5b18A:
18.1		 5t8hA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5T8H_B_478B401_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
ILE A  84
 None
 0.71A 5t8hA-5b18A:
18.1		 5t8hA-5b18A:
75.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_0
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.35A 6dgxA-5b18A:
18.5		 6dgxA-5b18A:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DGX_A_017A101_0
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
GLY A  49
PRO A  81
ILE A  84
 None
 0.83A 6dgxA-5b18A:
18.5		 6dgxA-5b18A:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH0_A_017A101_0
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
 None
 0.65A 6dh0A-5b18A:
18.5		 6dh0A-5b18A:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH3_A_017A101_0
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
ILE A  84
 None
 0.85A 6dh3A-5b18A:
18.4		 6dh3A-5b18A:
76.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_0
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.70A 6dh6A-5b18A:
18.3		 6dh6A-5b18A:
77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
ASP A  30
LEU A  76
ILE A  84
 None
 0.61A 6dh6B-5b18A:
17.5		 6dh6B-5b18A:
77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DH6_A_017A104_1
(PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 GLY A  27
ALA A  28
LEU A  76
PRO A  81
ILE A  84
 None
 0.51A 6dh6B-5b18A:
17.5		 6dh6B-5b18A:
77.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIF_B_TPVB201_0
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		5 / 12 ALA A  28
ASP A  29
ASP A  30
GLY A  49
ILE A  84
 None
 0.68A 6difA-5b18A:
18.2		 6difA-5b18A:
73.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIF_B_TPVB201_0
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
ALA A  28
ASP A  29
ASP A  30
PRO A  81
ILE A  84
 None
 0.47A 6difA-5b18A:
18.2		 6difA-5b18A:
73.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DIL_B_TPVB201_0
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
ALA A  28
ASP A  29
ASP A  30
GLY A  49
PRO A  81
 None
 1.22A 6dilA-5b18A:
18.1		 6dilA-5b18A:
72.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ1_B_AB1B201_0
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		7 / 12 GLY A  27
ALA A  28
ASP A  29
ASP A  30
GLY A  48
PRO A  81
ILE A  84
 None
 0.65A 6dj1A-5b18A:
18.1		 6dj1A-5b18A:
73.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ1_B_AB1B201_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
 None
 0.69A 6dj1B-5b18A:
18.0		 6dj1B-5b18A:
73.75
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6DJ2_B_AB1B201_1
(HIV-1 PROTEASE)		 5b18 PROTEASE
(Human
immunodeficiency
virus
1) 		6 / 12 ARG A   8
GLY A  27
ALA A  28
ASP A  29
ASP A  30
PRO A  81
 None
 0.63A 6dj2B-5b18A:
18.0		 6dj2B-5b18A:
72.50